EMBLEM™ MRI S-ICD System

Subcutaneous Implantable Defibrillator

EMBLEM S-ICD INSIGHT™ Technology

The EMBLEM S-ICD System uses the highly sophisticated INSIGHT technology to identify and classify a heart rhythm – rather than individual beats to effectively sense, discriminate, and convert VT/VF through a three phase process.

The SUBCUTANEOUS SIGNAL

The EMBLEM S-ICD System uses a revolutionary approach to sensing, different from transvenous systems:

ECG / EKG of subcutaneous signal

Far-field sensing allows the EMBLEM S-ICD System to capture a high-resolution signal similar to a surface ECG.
 
EMBLEM S-ICD sensing vectors

Three sensing vectors provide different perspectives of a patient’s cardiac rhythm for optimal sensing. EMBLEM S-ICD System automatically identifies the best signal for rhythm detection.

Therapy DELIVERY

Therapy DELIVERY

INSIGHT Technology

INSIGHT chart

PHASE I - Detection

The DETECTION phase filters the subcutaneous (S ECG) signal and generates detections for further analysis.  A variety of profiles are used for detection of signals, including the new SMART Pass filter which is used to further reduce cardiac oversensing.


PHASE II - Certification

The CERTIFICATION phase analyses the detected events and classifies them as cardiac or noise. Four separate algorithms are used to prevent oversensing and ensure an accurate heart rate.

PHASE III - Therapy Decision

During the Therapy Decision phase, the INSIGHT algorithm discriminates between treatable and other high-rate events such as AF, sinus tachycardia, and other SVTs, helping to avoid inappropriate therapy. The Conditional and Shock Zone settings are programmable.

S-ICD phase III therapy decision algorithms

The Therapy Decision phase also incorporates features to confirm that therapy delivery is necessary. These include SMART Charge, Charge Confirmation and Shock Confirmation. The SMART Charge feature enhances the EMBLEM S-ICD System‘s ability to prevent charging if non-sustained events are suspected and automatically extends initial detection time to allow for spontaneous termination.
Follow Boston Scientific Cardiology: Twitter LinkedIn YouTube Google+

Referências

Topo (Inicio)